Evaluation of macular integrity, after retinal detachment surgery, using MAIA microperimetry.

BACKGROUND AND OBJECTIVE: To describe visual function, macular integrity, and fixation stability using MAIA microperimetry (macular integrity assessment) after retinal detachment surgery. Evaluate if there are statistically significant differences between surgical approaches. MATERIALS AND METHODS: A prospective, comparative, interventional study was conducted, recruiting a total of 21 patients with rhegmatogenous retinal detachment and macula-off. Eleven patients underwent surgery using pars plana vitrectomy (PPV), and 10 patients underwent scleral buckle surgery. Clinical examinations and optical coherence tomography (OCT) were performed post-surgery. MAIA microperimetry was conducted at 6 months. RESULTS: Best-corrected visual acuity (BCVA) and the number of letters read improved over time in the operated eye but did not reach the level of the control eye (p = 0.001). No significant differences were found between the two surgical approaches in BCVA (p = 0.230) or the number of letters read (p = 0.608). Macular integrity in the operated eye did not match that of the control eye in both procedures (p = 0.05). No differences were detected between the two surgeries, either in macular integrity (p = 0.512) or fixation stability (p = 0.835). CONCLUSIONS: Following retinal detachment surgery, a decrease in BCVA and the number of letters read occurs, which does not reach the level of the control eye. No significant differences were observed between the two surgical approaches. Macular integrity in the operated eye does not match that of the control eye.

Actualización sobre las contraindicaciones en cirugía refractiva láser corneal / Update on contraindications in laser corneal refractive surgery

Los más de 25 años de experiencia con las técnicas de cirugía refractiva (desde que se aprobara por la Food and Drug Administration [FDA] de EE. UU. el uso del láser excímer en el remodelamiento de la córnea en 1995), sumado a los avances tecnológicos en oftalmología (láser de femtosegundo, ablación guida por topografía, sistemas de imagen de segmento anterior) y el mayor entendimiento de los errores refractivos, las aberraciones de alto orden y la biomecánica corneal, hacen que la cirugía refractiva corneal con láser sea un método seguro y eficaz para la corrección de estos defectos. Sin embargo, a día de hoy, siguen existiendo ciertas circunstancias que suponen una contraindicación para su aplicación, además de otras que podrían asociarse a complicaciones, y que deben ser analizadas con detenimiento.Esta revisión repasa las contraindicaciones actuales para la cirugía refractiva corneal con láser recogidas en los Protocolos de Práctica Preferente (PPP) de la Academia Estadounidense de Oftalmología y de la Sociedad Española de Oftalmología. Estos protocolos están basados en la mayor evidencia científica disponible en la actualidad y permiten extraer recomendaciones claras, mejorando el perfil de seguridad de estas técnicas.Las contraindicaciones pueden diferenciarse en relativas o absolutas; entre estas últimas están: la edad inferior a 18 años, la ausencia de estabilidad refractiva y la existencia de ciertas afecciones oculares (entre las que destacan determinadas distrofias corneales, queratocono, ojo seco mal controlado) o sistémicas (procesos autoinmunes activos o diabetes mellitus mal controlada)...(AU)

More than 25 years of experience with refractive surgery techniques (since the FDA [Food and Drug Administration] of the United States approved the use of the excimer laser in the remodeling of the cornea in 1995), added to the technological advances in ophthalmology (femtosecond laser, topography-guided ablation, anterior segment imaging systems) and increased understanding of refractive errors, higher order aberrations, and corneal biomechanics make corneal laser refractive surgery a safe method and effective for the correction of these defects. However, to date, there are still certain circumstances that represent a contraindication for its application, in addition to others that could be associated with complications, and that must be carefully analyzed.This review analyzes the current contraindications for laser corneal refractive surgery listed in the Preferred Practice Protocols (PPPs) of the American Academy of Ophthalmology and the Spanish Ophthalmology Society. These protocols are based on the best scientific evidence currently available and allow clear recommendations to be drawn, improving the safety profile of these techniques.Contraindications can be differentiated into relative or absolute; among the latter are: age less than 18 years, the absence of refractive stability and the existence of certain ocular pathologies (including certain corneal dystrophies, keratoconus, poorly controlled dry eye) or systemic pathologies (active autoimmune processes or poorly controlled diabetes mellitus). Other circumstances such as the use of certain drugs (amiodarone, isotretinoin), extreme values of mean central keratometry and pachymetry, history of previous uveitis or glaucoma, pregnancy and lactation, are considered relative contraindications according to the PPPs. However, there are studies that demonstrate the safety of refractive surgery in some of these cases. (AU)

Update on contraindications in laser corneal refractive surgery.

More than 25 years of experience with refractive surgery techniques (since the FDA [Food and Drug Administration] of the United States approved the use of the excimer laser in the remodeling of the cornea in 1995), added to the technological advances in ophthalmology (femtosecond laser, topography-guided ablation, anterior segment imaging systems) and increased understanding of refractive errors, higher order aberrations, and corneal biomechanics make corneal laser refractive surgery a safe method and effective for the correction of these defects. However, to date, there are still certain circumstances that represent a contraindication for its application, in addition to others that could be associated with complications, and that must be carefully analyzed. This review analyzes the current contraindications for laser corneal refractive surgery listed in the Preferred Practice Protocols (PPPs) of the American Academy of Ophthalmology and the Spanish Ophthalmology Society. These protocols are based on the best scientific evidence currently available and allow clear recommendations to be drawn, improving the safety profile of these techniques. Contraindications can be differentiated into relative or absolute; among the latter are: age less than 18 years, the absence of refractive stability and the existence of certain ocular pathologies (including certain corneal dystrophies, keratoconus, poorly controlled dry eye) or systemic pathologies (active autoimmune processes or poorly controlled diabetes mellitus). Other circumstances such as the use of certain drugs (amiodarone, isotretinoin), extreme values of mean central keratometry and pachymetry, history of previous uveitis or glaucoma, pregnancy and lactation, are considered relative contraindications according to the PPPs. However, there are studies that demonstrate the safety of refractive surgery in some of these cases.

Corrección de la presbicia tras cirugía cristaliniana. ¿Dónde nos encontramos en 2020? / Lens-based surgical correction of presbyopia. Where are we in 2020?

INTRODUCCIÓN: La presbicia es la pérdida progresiva e irreversible de la acomodación debido al envejecimiento. Es una de las principales causas de disminución de la calidad de vida en personas a partir de los 45 años derivada de la, muchas veces novedosa, dependencia de las gafas. El afán por corregirla por parte de los oftalmólogos, impulsados por el deseo de millones de personas que la padecen, se ha convertido en uno de los principales motores de desarrollo de la tecnología de las lentes intraoculares (LIO) durante los últimos 20 años. MATERIAL Y MÉTODOS: Esta revisión repasa las distintas alternativas que han permitido ir mejorando el enfoque quirúrgico cristaliniano de la presbicia; desde las lentes monofocales y la técnica de la monovisión, a las lentes acomodativas, pasando por las lentes multifocales refractivas y difractivas y terminando con las más recientes lentes de foco o campo extendido conocidas como EDOF. RESULTADOS: Cada una de estas LIO tiene sus ventajas, limitaciones e inconvenientes; y además, no existe la lente que se adapte a las necesidades de todos los pacientes. CONCLUSIONES: Es necesario conocer la variedad de lentes disponibles, y comprender en profundidad tanto sus propiedades ópticas como el impacto que estas van a tener luego en su rendimiento clínico y en la calidad visual de los pacientes. Esto nos debería ayudar a poder seleccionar la mejor alternativa para cada uno de ellos

INTRODUCTION: Presbyopia is the progressive and irreversible loss of accommodation due to aging. It is one of the main causes of loss of quality of life in people from 45 years of age, due to the, often novel, dependence on spectacles. The eagerness to correct it by ophthalmologists impulsed by the desire of millions of people who suffer from it, has become one of the main drivers for the development of intraocular lens (IOL) technology over the last twenty years. MATERIAL AND METHODS: This review briefly presents the different alternatives that have allowed us to improve the crystalline lens surgical approach of presbyopia; from monofocal lenses and monovision technique, accommodative, refractive, and diffractive multifocal lenses, and finally the most recent extended depth of focus/field lenses known as EDOFs. RESULTS: Each IOL has its advantages, limitations and disadvantages. Furthermore, there is no single lens that suits the needs of all patients. CONCLUSIONS: It is necessary to know the variety of lenses available, and to have an in-depth understanding of their optical properties, as well as the impact that these will have later on their clinical performance and on the visual quality of the patients. This should help us to select the best alternative for each of them

Lens-based surgical correction of presbyopia. Where are we in 2020? / Corrección de la presbicia tras cirugía cristaliniana. ¿Dónde nos encontramos en 2020?

INTRODUCTION: Presbyopia is the progressive and irreversible loss of accommodation due to aging. It is one of the main causes of loss of quality of life in people from 45 years of age, due to the, often novel, dependence on spectacles. The eagerness to correct it by ophthalmologists impulsed by the desire of millions of people who suffer from it, has become one of the main drivers for the development of intraocular lens (IOL) technology over the last twenty years. MATERIAL AND METHODS: This review briefly presents the different alternatives that have allowed us to improve the crystalline lens surgical approach of presbyopia; from monofocal lenses and monovision technique, accommodative, refractive, and diffractive multifocal lenses, and finally the most recent extended depth of focus/field lenses known as EDOFs. RESULTS: Each IOL has its advantages, limitations and disadvantages. Furthermore, there is no single lens that suits the needs of all patients. CONCLUSIONS: It is necessary to know the variety of lenses available, and to have an in-depth understanding of their optical properties, as well as the impact that these will have later on their clinical performance and on the visual quality of the patients. This should help us to select the best alternative for each of them.

Resultados visuales, independencia de gafas e insatisfacción tras implante de una lente intraocular difractiva trifocal / Visual outcomes, spectacle independence and satisfaction after diffractive trifocal intraocular lens implantation

OBJETIVO: Evaluar los resultados visuales, la independencia de gafas y la satisfacción tras el implante de una lente intraocular trifocal. MÉTODOS: Estudio retrospectivo de 5.186 sujetos intervenidos de facoemulsificación con implante de la lente trifocal difractiva FineVision Micro F12 (PhysIOL, Liège, Bélgica). RESULTADOS: La queratometría media preoperatoria fue 43,61±1,55 D y el cilindro queratométrico medio -0,86 ± 0,66 D. A los 3 meses, cambiaron a 43,59±1,56 y −0,71±0,46 D respectivamente. La esfera media pasó de 2,04±2,60 a 0,14±0,38 D y el equivalente esférico medio de 1,64±2,61 a −0,05±0,36 D. Más del 60% alcanzaron una mejor agudeza visual corregida de lejos. La mayoría presentó un defecto residual final (predictibilidad) menor de 1 D (99,1%). El 14,3% precisó un ajuste refractivo, el 2,2% capsulotomía posterior y se recolocó la lente intraocular en 5 casos. Un porcentaje elevado estaba satisfecho en términos de visión e independencia de gafas en todas las distancias. Aunque un 2% refirió un empeoramiento en la visión nocturna, únicamente un 2% estaba poco satisfecho y 20 pacientes insatisfechos. Las causas fueron: visión borrosa (7 casos), necesidad de gafas (10), disfotopsias (7) y sequedad ocular (4). CONCLUSIONES: La implantación de esta lente permite obtener buenos resultados visuales en las 3 distancias así como un alto grado de independencia de gafas y de satisfacción

PURPOSE: To investigate visual outcomes, spectacle independence, and patient satisfaction after trifocal intraocular lens implantation. METHODS: A retrospective study conducted on 5,186 patients who underwent phacoemulsification and were implanted with a diffractive trifocal intraocular lens (FineVision Micro F, PhysIOL SA, Liège, Belgium). RESULTS: The mean pre-operative keratometry was 43.61±1.55 D, and mean keratometric cylinder was -0.86±0.66 D. At 3 months post-operatively, values changed to 43.59±1.56 and -0.71±0.46 D, respectively. Mean sphere varied from 2.04±2.60 to 0.14±0.38 D, and mean spherical equivalent from 1.64±2.61 to -0.05±0.36 D. More than 60% of the patients achieved better corrected distance visual acuity. The majority had a final residual refractive error (predictability) lower than 1 D (99.1%), with 14.3% needing optical adjustment (bioptics). Posterior capsulotomy was performed in 2.2%, and the lens was replaced in 5 patients. A high percentage of patients were satisfied in terms of vision and spectacle independence at all distances. Although 2% referred to worsening of night vision quality, only 2% were not very satisfied and 20 patients were dissatisfied. The causes were: blurred vision (7 cases), spectacle dependence (10), dysphotopsia (7), and dry eye (4). CONCLUSIONS: The implantation of this model provided good visual performance in all distances, as well as high levels of spectacle independence and satisfaction

Visual outcomes, spectacle independence and satisfaction after diffractive trifocal intraocular lens implantation. / Resultados visuales, independencia de gafas e insatisfacción tras implante de una lente intraocular difractiva trifocal.

PURPOSE: To investigate visual outcomes, spectacle independence, and patient satisfaction after trifocal intraocular lens implantation. METHODS: A retrospective study conducted on 5,186 patients who underwent phacoemulsification and were implanted with a diffractive trifocal intraocular lens (FineVision Micro F, PhysIOL SA, Liège, Belgium). RESULTS: The mean pre-operative keratometry was 43.61±1.55 D, and mean keratometric cylinder was -0.86±0.66 D. At 3 months post-operatively, values changed to 43.59±1.56 and -0.71±0.46 D, respectively. Mean sphere varied from 2.04±2.60 to 0.14±0.38 D, and mean spherical equivalent from 1.64±2.61 to -0.05±0.36 D. More than 60% of the patients achieved better corrected distance visual acuity. The majority had a final residual refractive error (predictability) lower than 1 D (99.1%), with 14.3% needing optical adjustment (bioptics). Posterior capsulotomy was performed in 2.2%, and the lens was replaced in 5 patients. A high percentage of patients were satisfied in terms of vision and spectacle independence at all distances. Although 2% referred to worsening of night vision quality, only 2% were not very satisfied and 20 patients were dissatisfied. The causes were: blurred vision (7 cases), spectacle dependence (10), dysphotopsia (7), and dry eye (4). CONCLUSIONS: The implantation of this model provided good visual performance in all distances, as well as high levels of spectacle independence and satisfaction.

LASIK y ablación de superficie en pacientes tratados con amiodarona / LASIK and surface ablation in patients treated with amiodarone

OBJETIVO: Determinar los resultados anatómicos y funcionales de los pacientes intervenidos con cirugía refractiva corneal que estaban en tratamiento con amiodarona, la cual ha sido considerada como una posible contraindicación en estas intervenciones. MATERIAL Y MÉTODOS: Se ha realizado un estudio observacional retrospectivo. Los pacientes se incluyeron consecutivamente. Se incluyó a todos los pacientes que tomaban amiodarona y fueron operados mediante LASIK o ablación de superficie entre enero de 2003 y diciembre de 2014. Se pretenden describir los resultados funcionales (visuales y refractivos). RESULTADOS: Se incluyó a un total de 20 pacientes (33 ojos). No se encontraron complicaciones intraoperatorias o postoperatorias significativas. CONCLUSIONES: En nuestra experiencia los pacientes tratados con amiodarona e intervenidos mediante LASIK o ablación de superficie no presentaron complicaciones clínicas significativas. La contraindicación absoluta por tomar determinadas medicaciones sistémicas debería ser reconsiderada

OBJECTIVE: To determine the anatomical and functional outcomes of corneal refractive surgery in patients on amiodarone, a drug listed as being contraindicated in patients undergoing this procedure. MATERIAL AND METHODS: A retrospective observational study was conducted on all consecutive patients who took amiodarone and who underwent LASIK or surface ablation from January 2003 to December 2014. Functional (visual and refractive) outcomes are described. RESULTS: A total of 20 patients (33 eyes) were included. No significant intraoperative or postoperative complications were found. CONCLUSIONS: In our experience, LASIK and surface ablation did not produce significant clinical complications in selected patients taking amiodarone. The absolute exclusion of certain systemic medications should be reconsidered

Reacción ocular adversa a la acetazolamida: a propósito de un caso / Severe ocular side effects with acetazolamide: case report

CASO CLÍNICO: Mujer de 44 años que acude a urgencias por disminución de la agudeza visual (AV) en ambos ojos (AO) de 4h de evolución. Se observa miopización, aumento de la presión intraocular (PIO) en AO y cámara anterior (CA) de grado II. En la ecografía de segmento posterior se evidencia un desprendimiento coroideo en rodete periférico y en la de segmento anterior se mide un grosor cristaliniano de 4,05mm en el ojo derecho (OD) y 4,00mm en el ojo izquierdo (OI). La paciente está en tratamiento (vía oral) con naproxeno y acetazolamida, por migraña. Se suspende el tratamiento con acetazolamida y se pauta tratamiento tópico con timolol y brimonidina cada 12h, y prednisolona y ciclopentolato cada 8h. En los controles sucesivos se observa una disminución progresiva de la miopía, del grosor del cristalino y una ampliación de la cámara anterior. En el último control, el paciente acepta una esfera de −0,75 dioptrías (D) en el OD y de −0,25 D en el OI, la PIO es de 15mmHg en AO y la CA es de grado III. En la ecografía, el grosor del cristalino es de 3,59mm en el OD y de 3,61mm en el OI. Conclusión: Se trata de un caso de cierre angular agudo por desplazamiento del complejo irido-cristaliniano de causa iatrogénica, secundario al uso de acetazolamida. El tratamiento de esta entidad consiste en retirar el fármaco responsable del cuadro y administrar corticoides, hipotensores y ciclopléjico tópicos. Con esto se consigue disminuir la presión ocular y el grado de miopía gracias al reposicionamiento del diafragma irido-cristaliniano

CLINICAL CASE: A 44-year-old woman arrived in the emergency department complaining of decreased visual acuity (VA) in oculus uterque (OU) of 4hours onset. Signs of myopia, increased intraocular pressure (IOP) in OU, and a narrow grade II anterior chamber (AC) were observed. In the posterior segment ultrasound scan, a choroidal peripheral detachment is evident, and a lenticular thickness of 4.05mm is measured in the anterior segment of the right eye (OD) and 4.00mm in the left eye (OS). On treatment with oral with naproxen (non-steroidal anti-inflammatory drug), and acetazolamide for migraine. The acetazolamide is suspended and topical treatment is started with timolol and brimonidine every 12hours, with prednisolone and ayclopentolate every 8hours. In the follow-up, a gradual reduction of myopia and lens thickness is observed, as well as anterior chamber expansion. In the last control, the patient had a sphere of −0.75 diopters (D) in OD and −0.25 D in OS. IOP was 15mmHg in OU and AC was grade III. The ultrasound showed a lens thickness of 3.59mm in OD and 3.61mm in OS. Conclusion: This was an iatrogenic case of acute angle closure induced by an anterior displacement of the irido-lenticular complex, secondary to the use of acetazolamide. The treatment of this condition involves suspending the drug responsible and applying topical corticosteroids, hypotensive and cycloplegic eye drops, with the aim of lowering the eye pressure and the degree of myopia due to the re-positioning of the irido-lenticular complex

LASIK and surface ablation in patients treated with amiodarone. / LASIK y ablación de superficie en pacientes tratados con amiodarona.

OBJECTIVE: To determine the anatomical and functional outcomes of corneal refractive surgery in patients on amiodarone, a drug listed as being contraindicated in patients undergoing this procedure. MATERIAL AND METHODS: A retrospective observational study was conducted on all consecutive patients who took amiodarone and who underwent LASIK or surface ablation from January 2003 to December 2014. Functional (visual and refractive) outcomes are described. RESULTS: A total of 20 patients (33 eyes) were included. No significant intraoperative or postoperative complications were found. CONCLUSIONS: In our experience, LASIK and surface ablation did not produce significant clinical complications in selected patients taking amiodarone. The absolute exclusion of certain systemic medications should be reconsidered.

Severe ocular side effects with acetazolamide: case report. / Reacción ocular adversa a la acetazolamida: a propósito de un caso.

CLINICAL CASE: A 44-year-old woman arrived in the emergency department complaining of decreased visual acuity (VA) in oculus uterque (OU) of 4hours onset. Signs of myopia, increased intraocular pressure (IOP) in OU, and a narrow grade II anterior chamber (AC) were observed. In the posterior segment ultrasound scan, a choroidal peripheral detachment is evident, and a lenticular thickness of 4.05mm is measured in the anterior segment of the right eye (OD) and 4.00mm in the left eye (OS). On treatment with oral with naproxen (non-steroidal anti-inflammatory drug), and acetazolamide for migraine. The acetazolamide is suspended and topical treatment is started with timolol and brimonidine every 12hours, with prednisolone and ayclopentolate every 8hours. In the follow-up, a gradual reduction of myopia and lens thickness is observed, as well as anterior chamber expansion. In the last control, the patient had a sphere of -0.75 diopters (D) in OD and -0.25 D in OS. IOP was 15mmHg in OU and AC was grade III. The ultrasound showed a lens thickness of 3.59mm in OD and 3.61mm in OS. CONCLUSION: This was an iatrogenic case of acute angle closure induced by an anterior displacement of the irido-lenticular complex, secondary to the use of acetazolamide. The treatment of this condition involves suspending the drug responsible and applying topical corticosteroids, hypotensive and cycloplegic eye drops, with the aim of lowering the eye pressure and the degree of myopia due to the re-positioning of the irido-lenticular complex.

Ectasia corneal post-LASIK en pacientes con diferencias significativas en las lecturas queratométricas de ambos ojos / Post-lasik corneal ectasia in patients with significant differences in keratometry readings between both eyes

OBJETIVOS: Investigar la incidencia de ectasia corneal tras queratomileusis in situ asistida por láser excímer (LASIK) en pacientes con diferencias significativas en la lectura queratométrica media (KM) entre ambos ojos (AO). Además se evalúan los resultados visuales. MÉTODOS: Se han revisado las historias clínicas de 164.603 pacientes (315.259 ojos) intervenidos con LASIK de enero de 2003 a diciembre de 2011 para identificar pacientes con una diferencia de KM ≥ 1,25 D entre AO. Además de este criterio, debían ser pacientes miopes con topografía corneal normal. Las principales variables de estudio fueron la incidencia de ectasia tras LASIK y el resultado visual. RESULTADOS: Un total de 35 ojos de 20 pacientes cumplieron con los criterios de inclusión y exclusión. Los resultados funcionales y visuales fueron los esperados para las refracciones estudiadas. No se encontraron ectasias en la serie estudiada tras un seguimiento mínimo de 2 años. CONCLUSIONES: La posibilidad de encontrar en un paciente asimetría de KM y topografía normal es pequeña (0,021%) y no parece ser una contraindicación para realizar LASIK. A pesar de no encontrarse ectasias en la serie estudiada, ya que esta es una complicación potencialmente grave para la visión, los pacientes con elevadas diferencias en la KM entre AO deben ser estudiados cuidadosamente antes de ser intervenidos mediante LASIK

OBJECTIVES: A study is made on the incidence of corneal ectasia after laser in situ keratomileusis (LASIK) in patients with large differences in mean keratometry (MK) readings between both eyes (OU). Visual outcomes were also evaluated. METHODS: The medical records of 164,603 patients (315,259 eyes) who underwent LASIK from January 2003 to December 2011 were reviewed in order to identify patients with a difference in MK of ≥ 1.25 D between OU. The main outcome measures were incidence of ectasia after LASIK, and visual outcome. RESULTS: A total of 35 eyes that met the inclusion criteria were found. Functional and visual results were those expected for myopia studies. After a minimum follow-up of 2 years, no corneal ectasia was found in 3 eyes (2 patients). CONCLUSIONS: The possibility of finding a patient with an asymmetry in MK and normal topography is low (0.021%), and it does not seem to be a contraindication of LASIK. Although no corneal ectasia was found in this case series, and as it is a potentially sight-threatening complication, patients with very different MK between OU should be studied carefully before undergoing LASIK

[Post-lasik corneal ectasia in patients with significant differences in keratometry readings between both eyes]. / Ectasia corneal post-LASIK en pacientes con diferencias significativas en las lecturas queratométricas de ambos ojos.

OBJECTIVES: A study is made on the incidence of corneal ectasia after laser in situ keratomileusis (LASIK) in patients with large differences in mean keratometry (MK) readings between both eyes (OU). Visual outcomes were also evaluated. METHODS: The medical records of 164,603 patients (315,259 eyes) who underwent LASIK from January 2003 to December 2011 were reviewed in order to identify patients with a difference in MK of ≥ 1.25 D between OU. The main outcome measures were incidence of ectasia after LASIK, and visual outcome. RESULTS: A total of 35 eyes that met the inclusion criteria were found. Functional and visual results were those expected for myopia studies. After a minimum follow-up of 2 years, no corneal ectasia was found in 3 eyes (2 patients). CONCLUSIONS: The possibility of finding a patient with an asymmetry in MK and normal topography is low (0.021%), and it does not seem to be a contraindication of LASIK. Although no corneal ectasia was found in this case series, and as it is a potentially sight-threatening complication, patients with very different MK between OU should be studied carefully before undergoing LASIK.